首页> 外文期刊>Pharmacology and Toxicology: An International Journal >Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
【24h】

Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.

机译:帕金森氏病中的铜,铜蓝蛋白,超氧化物歧化酶和铁参数。

获取原文
获取原文并翻译 | 示例
       

摘要

In a previous study we found copper dyshomeostasis in patients with Alzheimer's disease. In this study, levels of copper in plasma, of ceruloplasmin in serum and ceruloplasmin oxidative activity as well as superoxide dismutase (SOD) activity in erythrocytes were determined in 40 patients with Parkinson's disease and their healthy age- and gender-matched controls. Copper concentrations did not differ significantly in the two groups, whereas both ceruloplasmin concentrations and ceruloplasmin oxidative activity were significantly lower in the patients, also relative to ceruloplasmin mass. SOD activity was not significantly different in the two groups but decreased significantly with the duration of disease. The same was found for ceruloplasmin oxidative activity. Ceruloplasmin oxidative activity and SOD activity did not decrease with age. Levels of serum iron, serum ferritin and total iron binding capacity were determined in about 30 of the patients and an equal number of controls and were not found to differ. Transferrin levels were significantly lower in the patients than in their controls but, conversely, the transferrin saturation was significantly higher in the patients. The results indicate that patients with Alzheimer's disease and Parkinson's disease have defective ceruloplasmin and SOD activities in common and that these defects are not necessarily associated with major disturbances in iron homeostasis.
机译:在先前的研究中,我们发现阿尔茨海默氏病患者的铜异位症。在这项研究中,确定了40名帕金森氏病患者及其健康的年龄和性别匹配的对照者的血浆铜水平,血清铜蓝蛋白和血清铜蓝蛋白的氧化活性以及红细胞中的超氧化物歧化酶(SOD)活性。两组的铜浓度无显着差异,而患者血浆铜蓝蛋白浓度和铜蓝蛋白氧化活性均显着降低,相对于铜蓝蛋白质量也是如此。两组的SOD活性无明显差异,但随着病程的延长而显着降低。铜蓝蛋白的氧化活性也相同。铜蓝蛋白的氧化活性和SOD活性没有随着年龄的增长而降低。在约30名患者和相同数量的对照中测定了血清铁,血清铁蛋白和总铁结合能力的水平,未发现差异。患者中的转铁蛋白水平显着低于对照组,但相反,患者中的转铁蛋白饱和度显着更高。结果表明,患有阿尔茨海默氏病和帕金森氏病的患者普遍具有缺陷的铜蓝蛋白和SOD活性,这些缺陷不一定与铁稳态的重大障碍有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号